Dr. Luis Garza, MD, PhD
Claim this profileJohns Hopkins Hospital
Studies Amputation
Studies Dermabrasion
4 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Luis Garza, MD, PhD is currently running
Fibroblast Injection
for Amputee Limb Care
The study will enroll 20 adults ages 18-75 with a transtibial amputation with mature residual limbs who are ambulatory prosthesis users. Participants will be randomized to either treatment with low dose volar fibroblast injections (n=10) or to vehicle control (n=10). Participants will undergo a biopsy to harvest volar skin for fibroblast expansion and tattooing to identify injection sites on the residual limb. Fibroblasts will be processed at the Hopkins Cellular Therapy Core Lab and volar cells primed for injection will be sent to participating centers for administration. Participants randomized to the treatment group will be treated with low-dose cells. Injections will be administered on at least 1 and up to three separate days over the course of one week. Participants randomized to the vehicle control group will receive injection of cryoprotectant. All participants will be followed at 2 weeks, 1, 2, and 3 months after the last injection. These visits will include a clinical evaluation for complications, non-invasive assessments of skin firmness and thickness, skin appearance, and patient-reported outcomes. After the final monitoring visit, individuals randomized to the vehicle control group will have the opportunity to receive the volar fibroblast injections and will be followed for an additional 3 months. The investigators hypothesize that (1) There will be no difference in the rate of serious adverse events among patients treated with volar fibroblast injections compared with patients treated with vehicle control, and (2) Patients treated with volar fibroblast injections will have firmer skin on the residual limb compared with patients tread with vehicle alone.
Recruiting1 award Phase 28 criteria
Autologous Skin Grafts
for Wounds and Injuries
This research is being done to determine if investigators can change skin from one type to another. Specifically, investigators are interested in making normal skin into the thicker skin found on our palms and soles.
Recruiting1 award Phase 2
More about Luis Garza, MD, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Luis Garza, MD, PhD has experience with
- Autologous Skin Fibroblasts
- Placebo
- Laser
- Retinoic Acid
- Sham Treatment
- Autologous Volar Fibroblast Injection
Breakdown of trials Luis Garza, MD, PhD has run
Dermabrasion
Hair Loss
Central Centrifugal Alopecia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Luis Garza, MD, PhD specialize in?
Luis Garza, MD, PhD focuses on Amputation and Dermabrasion. In particular, much of their work with Amputation has involved treating patients, or patients who are undergoing treatment.
Is Luis Garza, MD, PhD currently recruiting for clinical trials?
Yes, Luis Garza, MD, PhD is currently recruiting for 3 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Luis Garza, MD, PhD has studied deeply?
Yes, Luis Garza, MD, PhD has studied treatments such as Autologous Skin Fibroblasts, Placebo, Laser.
What is the best way to schedule an appointment with Luis Garza, MD, PhD?
Apply for one of the trials that Luis Garza, MD, PhD is conducting.
What is the office address of Luis Garza, MD, PhD?
The office of Luis Garza, MD, PhD is located at: Johns Hopkins Hospital, Baltimore, Maryland 21287 United States. This is the address for their practice at the Johns Hopkins Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.